- Treatment of tinea capitis in patients 4 years of age and older
Coverage of drugs is first determined by the member’s pharmacy or medical benefit. Please consult with or refer to the Evidence of Coverage document.
Drug | Dosing Regimen | Dose Limit/ Maximum Dose |
---|---|---|
tolnaftate (various brands) 1% cream, soln, powder, spray powder/liquid | Apply to affected area BID for 2-4 weeks. | This section intentionally left blank |
griseofulvin microsize tablets (Grifulvin VR) | Adults: 500 mg PO QD or in divided doses for 4-6 weeks Children: | 1000 mg/day |
itraconazole (SporanoxR)* | 3-5 mg/kg PO QD for 4-6 weeks (non FDA approved) | 5 mg/kg/day |
griseofulvin ultramicrosize tablets (Gris-PEGR) | Adults: 300 mg - 375 mg PO QD or in divided doses for 4-6 weeks Children: 5 - 15 mg/kg PO QD for 4 - 6 weeks Gris-PEG is only FDA indicated for children > 2yrs | 750 mg/day |
Drug | Dosing Regimen | Authorization Limit |
---|---|---|
Lamisil (terbinafine granules) | <25 kg patient: 125 mg PO QD 25-35 kg patient: 187.5 mg PO QD >35 kg patient: 250 mg PO QD | 6 weeks |